Simultaneously quantitative measurement of comprehensive profiles of esterified and non-esterified fatty acid in plasma of type 2 diabetic patients

Chemistry and Physics of Lipids

Volumn 150, Issue 2, 2007, Pages 204-216

  Yi, Lunzhao ^a   He, Jun ^a   Liang, Yizeng ^a   Yuan, Dalin ^a   Gao, Haiyan ^a   Zhou, Honghao ^a  

^a CENTRAL SOUTH UNIVERSITY   (China)

Author keywords

Fatty acids profiling; GC MS; Rosiglitazone; Type 2 diabetes mellitus

Indexed keywords

FATTY ACID; METHANOL; POTASSIUM HYDROXIDE; ROSIGLITAZONE; SULFURIC ACID;

ADULT; AGED; ARTICLE; CONTROLLED STUDY; DIABETIC PATIENT; ESTERIFICATION; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHYLATION; NON INSULIN DEPENDENT DIABETES MELLITUS; PLASMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STUDENT T TEST;

ADULT; AGED; CALIBRATION; CHROMATOGRAPHY, THIN LAYER; DIABETES MELLITUS, TYPE 2; ESTERS; FATTY ACIDS; FEMALE; GAS CHROMATOGRAPHY-MASS SPECTROMETRY; HUMANS; MALE; METHYLATION; MIDDLE AGED; MULTIVARIATE ANALYSIS; OLEIC ACID; REPRODUCIBILITY OF RESULTS; THIAZOLIDINEDIONES; TIME FACTORS;

EID: 35148842027     PISSN: 00093084     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.chemphyslip.2007.08.002     Document Type: Article

References (26)

1. Bergman R.N., and Ader M. Free fatty acids and pathogenesis of type 2 diabetes mellitus. Trends Endocrin. Met. 11 (2000) 351-356
2. Boden G. Free fatty acids, insulin resistance, and type 2 diabetes mellitus. Proc. Assoc. Am. Phys. 3 (1999) 241-248
3. Boden G., and Chen X. Effects of fat on glucose uptake and utilization in patients with non-insulin-dependent diabetes. J. Clin. Invest. 96 (1995) 1261-1268
4. Bravi E., Perretti G., and Montanari L. Fatty acids by high-performance liquid chromatography and evaporative light-scattering detector. J. Chromatogr. A 1134 (2006) 210-214
5. Girard J. Contribution of free fatty acids to impairment of insulin secretion and action mechanism of beta-cell lipotoxicity. Med. Sci. (Paris) 21 (2005) 19-25
6. Hajimahmoodi M., Vander Heyden Y., Sadeghi N., Jannat B., Oveisi M.R., and Shahbazian S. Gas-chromatographic fatty-acid fingerprints and partial least squares modeling as a basis for the simultaneous determination of edible oil mixtures. Talanta 66 (2005) 1108-1116
7. Hvattum E., Uran S., Sandbaek A.G., Karlsson A.A., and Skotland T. Quantification of phosphatidylserine, phosphatidic acid and free fatty acids in an ultrasound contrast agent by normal-phase high-performance liquid chromatography with evaporative light scattering detection. J. Pharm. Biomed. 42 (2006) 506-512
8. Junga H.S., Younb B.S., Choa Y.M., and Yub K.Y. The effects of rosiglitazone and metformin on the plasma concentrations of resistin in patients with type 2 diabetes mellitus. Metabolism 54 (2005) 314-320
9. Lebovitz H.E., and Banerji M.A. Treatment of insulin resistance in diabetes mellitus. Eur. J. Pharmacol. 490 (2004) 135-146
10. Masukawa Y., Tsujimura H., and Imokawa G. A systematic method for the sensitive and specific determination of hair lipids in combination with chromatography. J. Chromatogr. B 823 (2005) 131-142
11. Miyazaki Y., Glass L., Triplitt C., Matsuda M., Cusi K., Mahankali A., Mahankali S., Mandarino L.J., and DeFronzo R.A. Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in type II diabetic patients. Diabetologia 44 (2004) 2210-2219
12. Moller D.E. New drug targets for type 2 diabetes and the metabolic syndrome. Nature 414 (2001) 821-827
13. Moller D.E., and Greene D.A. Peroxisome proliferator-activated receptor (PPAR) gamma agonists for diabetes. Adv. Prot. Chem. (Drug Discovery) 56 (2001) 181-212
14. Patterson B.W., Zhao G.H., Elias N., Hachey D.L., and Klein S. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J. Lipid Res. 40 (1999) 2118-2124
15. Reaven G.M., and Chen Y.D. Role of abnormal free fatty acid metabolism in the development of non-insulin dependent diabetes mellitus. Am. J. Med. 85 Suppl. 5A (1988) 106-113
16. Seppanen-Laakso T., Laakso I., and Hiltunen R. Analysis of fatty acids by gas chromatography, and its relevance to research on health and nutrition. Anal. Chim. Acta 465 (2002) 39-62
17. Stumvoll M., Goldstein B.J., and Haeften T.W.V. Type 2 diabetes: principles of pathogenesis and therapy. Lancet 365 (2005) 1333-1346
18. Suresh Y., and Das U.N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of [omega]-3 fatty acids. Nutrition 19 (2003) 213-228
19. Suresh Y., and Das U.N. Long-chain polyunsaturated fatty acids and chemically induced diabetes mellitus: effect of [omega]-6 fatty acids. Nutrition 19 (2003) 93-114
20. van Wijk J.P.H., de Koning E.J.P., Castro Cabezas M., and Rabelink T.J. Rosiglitazone improves postprandial triglyceride and free fatty acid metabolism in type 2 diabetes. Diab. Care 28 (2005) 844-849
21. Willson T.M., Brown P.J., Sternbach D.D., and Henke B.R. The PPARs: from orphan receptors to drug discovery. J. Med. Chem. 43 (2000) 527-550
22. Wyne K.L. Free fatty acids and type 2 diabetes mellitus. Am. J. Med. 115 (2003) 29-36
23. Yang J., Xu G., Hong Q., Liebich H.M., Lutz K., Schmulling R.M., and Wahl H.G. Discrimination of type 2 diabetic patients from healthy controls by using metabonomics method based on their serum fatty acid profiles. J. Chromatogr. B 813 (2004) 53-58
24. Yi L.Z., Liang Y.Z., Zeng Z.D., Wang P., and Yuan D.L. Comparative analysis of volatile constituents in Chenpi of different original plants by GC-MS and AMWFA. Chem. J. Chinese U. 27 (2006) 1626-1630
25. You J., Zhao X., Suo Y., Li Y., Wang H., and Chen G. Determination of long-chain fatty acids in bryophyte plants extracts by HPLC with fluorescence detection and identification with MS. J. Chromatogr. B 848 (2007) 283-291
26. Zeng Z.D., Liang Y.Z., Wang Y.L., Li X.R., Liang L.M., Xu Q.S., Zhao C.X., Li B.Y., and Chau F.T. Alternative moving window factor analysis (AMWFA) for comparison analysis between complex chromatographic data. J. Chromatogr. A 1107 (2006) 273-285